Swiss Life Asset Management Ltd Grows Position in Agilent Technologies, Inc. $A

Swiss Life Asset Management Ltd boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 9.8% during the 4th quarter, Holdings Channel reports. The firm owned 75,433 shares of the medical research company’s stock after acquiring an additional 6,730 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Agilent Technologies were worth $10,264,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. Board of the Pension Protection Fund purchased a new stake in Agilent Technologies during the 4th quarter worth approximately $27,000. Physician Wealth Advisors Inc. grew its position in Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after purchasing an additional 196 shares during the last quarter. Torren Management LLC purchased a new stake in Agilent Technologies during the 4th quarter worth approximately $32,000. State of Wyoming purchased a new stake in Agilent Technologies during the 2nd quarter worth approximately $35,000. Finally, Johnson Financial Group Inc. purchased a new stake in Agilent Technologies during the 3rd quarter worth approximately $49,000.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on A. Barclays reduced their target price on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. TD Cowen decreased their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Wells Fargo & Company decreased their target price on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. Wall Street Zen downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, HSBC assumed coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $112.93 on Wednesday. The company’s fifty day moving average price is $115.46 and its 200 day moving average price is $131.30. Agilent Technologies, Inc. has a 1 year low of $107.07 and a 1 year high of $160.27. The company has a market capitalization of $31.91 billion, a PE ratio of 24.93, a price-to-earnings-growth ratio of 2.35 and a beta of 1.22. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same period last year, the company posted $1.31 earnings per share. The business’s quarterly revenue was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.